Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $70.1M | 0.02% |
1,465,844
+252,580
| +21% | +$12M |
|
602
Rollins
ROL
$18B
| $70M | 0.02% |
1,915,789
+32,996
| +2% | +$1.28M |
|
603
Pacer Lunt Large Cap Alternator ETF
ALTL
$94.3M
| $69.9M | 0.02% |
1,731,937
+1,078,958
| +165% | +$42.4M |
|
604
Huntington Bancshares
HBAN
$35.6B
| $69.6M | 0.02% |
4,935,158
+696,739
| +16% | +$10.1M |
|
605
Schwab US Mid-Cap ETF
SCHM
$15B
| $69.4M | 0.02% |
3,173,724
-203,610
| -6% | -$4.46M |
|
606
Charles River Laboratories
CRL
$12.3B
| $69.4M | 0.02% |
318,497
+299,953
| +1,618% | +$65.5M |
|
607
Visteon
VC
$2.79B
| $68.7M | 0.02% |
524,770
-219,168
| -29% | -$29.2M |
|
608
Lattice Semiconductor
LSCC
$18B
| $68.3M | 0.02% |
1,053,479
+579,121
| +122% | +$34.9M |
|
609
Avient
AVNT
$3.5B
| $68.3M | 0.02% |
2,022,110
+278,687
| +16% | +$9.16M |
|
610
Charter Communications
CHTR
$18B
| $68.1M | 0.02% |
200,912
-7,817
| -4% | -$2.75M |
|
611
Paylocity
PCTY
$7.78B
| $68M | 0.02% |
350,010
-40,644
| -10% | -$8.73M |
|
612
BILL Holdings
BILL
$4.82B
| $67.9M | 0.02% |
623,162
-4,386
| -0.7% | -$527K |
|
613
3M
MMM
$94.2B
| $67.7M | 0.02% |
675,443
+41,958
| +7% | +$4.28M |
|
614
Generac Holdings
GNRC
$13.1B
| $67.3M | 0.02% |
670,062
-149,713
| -18% | -$16.9M |
|
615
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34B
| $67.2M | 0.02% |
1,953,520
+104,280
| +6% | +$3.73M |
|
616
Sempra
SRE
$55.2B
| $67.1M | 0.02% |
867,764
-40,798
| -4% | -$3.16M |
|
617
Live Oak Bancshares
LOB
$2.03B
| $66.9M | 0.02% |
2,216,885
+489,693
| +28% | +$15.6M |
|
618
Ares Capital
ARCC
$13.8B
| $66.7M | 0.02% |
3,608,549
+4,102
| +0.1% | +$77K |
|
619
Rockwell Automation
ROK
$50.4B
| $66.5M | 0.02% |
280,904
-19,730
| -7% | -$4.95M |
|
620
Vanguard S&P 500 Growth ETF
VOOG
$27.1B
| $66.5M | 0.02% |
1,890,348
+1,133,148
| +150% | +$40.9M |
|
621
Live Nation Entertainment
LYV
$42.7B
| $65.8M | 0.02% |
943,386
-490,201
| -34% | -$36.3M |
|
622
Ameris Bancorp
ABCB
$6B
| $65.7M | 0.02% |
1,392,979
-25,913
| -2% | -$1.3M |
|
623
iShares ESG Aware MSCI EM ETF
ESGE
$6.76B
| $65.7M | 0.02% |
2,182,524
+42,963
| +2% | +$1.26M |
|
624
Zscaler
ZS
$26.2B
| $65.6M | 0.02% |
586,475
-235,330
| -29% | -$32M |
|
625
Houlihan Lokey
HLI
$8.95B
| $65.5M | 0.02% |
752,013
-227,143
| -23% | -$20.4M |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.